Phase 1 Bipolar Depression Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1
Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
Treatment-resistant Bipolar Depression
The University of Texas Health Science Center, Houston30 enrolled1 locationNCT03522545
Recruiting
Phase 1Phase 2
Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
Bipolar Depression
Laureate Institute for Brain Research, Inc.20 enrolled1 locationNCT06088732
Recruiting
Phase 1
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
Bipolar Depression
University Health Network, Toronto30 enrolled1 locationNCT06506019